• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 3.39% Nasdaq Down 4.12%

    Esperion Therapeutics, Inc. (ESPR)

    -NasdaqGM
    16.12 Down 0.78(4.62%) Jun 24, 4:00PM EDT
    |After Hours : 16.12 0.00 (0.00%) Jun 24, 7:20PM EDT
    Prev Close:16.90
    Open:15.80
    Bid:16.13 x 500
    Ask:18.50 x 100
    1y Target Est:47.46
    Beta:1.92253
    Earnings Date:Aug 4 - Aug 8 (Est.)
    Day's Range:15.51 - 17.15
    52wk Range:12.61 - 100.98
    Volume:886,092
    Avg Vol (3m):315,530
    Market Cap:363.36M
    P/E (ttm):N/A
    EPS (ttm):-2.35
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ESPR

    Comparison

    Symbol% ChgMkt Cap
    ESPRDown 4.62%363.36M
    PFEDown 1.79%206.02B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-3.76
    Quarterly EPS Est (Jun-16) :-0.82
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):-0.19

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of oral and low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of patients with elevated LDL-C. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback